IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel H. Johnson(The University of Texas MD Anderson Cancer Center), Adi Diab(Cleveland Clinic)
Cited by 112
Related Papers
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
|Cancer Cell|2020|379
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
|Journal of Clinical Oncology|2023|69
Evidence for viable, non-clonal but fatherless Boa constrictors
|Biology Letters|2010|68